½ÃÀ庸°í¼­
»óǰÄÚµå
1594369

¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : ±â±â À¯Çü, ½Ã·Â ¼öÁØ, ¿¬·É´ë, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Multi-Parameter Patient Monitoring Systems Market by Device Type (Fixed, Portable), Acuity level (High, Low, Medium), Age Group, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀº 2023³â 163¾ï 9,000¸¸ ´Þ·¯·Î Æò°¡µÇ°í 2024³â¿¡´Â 177¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 8.77% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 295¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ(MPPM)Àº ½É¹Ú¼ö, Ç÷¾Ð, È£Èí¼ö, ü¿Â µî ¿©·¯ »ý¸®Àû ¡Èĸ¦ µ¿½Ã¿¡ ÃßÀûÇϵµ·Ï ¼³°èµÈ ÀÇ·á ȯ°æ¿¡ ÇʼöÀûÀÎ ½Ã½ºÅÛÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀÇ Çʿ伺Àº ƯÈ÷ ÁßȯÀÚ½Ç, ÀÀ±Þ½Ç, ¼ö¼ú½Ç µî¿¡¼­ ȯÀÚ¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇϰí ÇÊ¿äÇÒ ¶§ Áï°¢ÀûÀÎ ÀÓ»óÀû °³ÀÔÀ» ÇÒ ¼ö ÀÖ´Â ´É·Â¿¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ÁÖ·Î º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ ¹× ÀçÅà ÀÇ·á ÇöÀå¿¡¼­ »ç¿ëµÇ°í ÀÖÀ¸¸ç, ÀûÀÀ¼ºÀÌ ¶Ù¾î³ª°í ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ÀÇ Áõ°¡, ¿øÈ°ÇÑ ¿¬°áÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ¹«¼± Åë½Å ±â¼úÀÇ ¹ßÀü µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³ÀÎÈ­µÈ ÀÇ·á ¼­ºñ½º·ÎÀÇ Àüȯ°ú MPPM°ú ¿ø°ÝÀÇ·á ¼­ºñ½ºÀÇ ÅëÇÕÀº ½ÃÀå È®´ëÀÇ Å« ±âȸ·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±â¾÷µéÀº AI ±â¹Ý ºÐ¼®°ú IoT ÅëÇÕ¿¡ ÅõÀÚÇÏ¿© ¿¹ÃøÀû ÀλçÀÌÆ®¿Í ȯÀÚ °ü¸® °³¼±À» Á¦°øÇÔÀ¸·Î½á ÀÌ·¯ÇÑ Ãß¼¼¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÃÀå ¼ºÀå¿¡´Â ÷´Ü ½Ã½ºÅÛ°ú °ü·ÃµÈ ³ôÀº ºñ¿ë, ±ÔÁ¦ Áؼö ¹®Á¦, ÀÌ·¯ÇÑ ÀåÄ¡¸¦ Á¶ÀÛÇÒ ¼ö ÀÖ´Â ¼÷·ÃµÈ Àη¿¡ ´ëÇÑ ¿ä±¸ »çÇ× µî ¿©·¯ °¡Áö µµÀü°úÁ¦°¡ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¥ÀÌÅÍ º¸¾È ¹× ÇÁ¶óÀ̹ö½Ã ¹®Á¦°¡ ´ëµÎµÇ°í ÀÖ¾î »çÀ̹ö º¸¾È¿¡ ´ëÇÑ Çõ½ÅÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº °¡Á¤ ³» °¨½Ã¸¦ ¿ëÀÌÇÏ°Ô ÇÏ´Â ¼ÒÇüÈ­ ¹× ÈÞ´ë¿ë ±â±âÀÇ ¹ßÀü°ú ÇÔ²² ±Þ¼ÓÇÑ ±â¼ú ¹ßÀüÀÌ Æ¯Â¡ÀÔ´Ï´Ù. °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ±â¾÷µéÀº ºñ¿ë È¿À²ÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀ̸ç ÈÞ´ë°¡ °£ÆíÇÑ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç °³¹ß¿¡ ÁýÁßÇϰí, ¿¹Ãø ´É·ÂÀ» Çâ»ó½Ã۱â À§ÇØ ¸Ó½Å·¯´× ¿¬±¸¿¡ ÅõÀÚÇØ¾ß ÇÕ´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ±â¼ú ±â¾÷ ¹× ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿ÍÀÇ ÆÄÆ®³Ê½ÊÀ» ±¸ÃàÇϰí Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» °øµ¿ °³¹ßÇÏ´Â °ÍÀº Àü·«Àû ¼ºÀåÀÇ ±æÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌó·³ MPPM ½ÃÀå¿¡´Â ÃæºÐÇÑ ±âȸ°¡ ÀÖÁö¸¸, Àå¾Ö¹°À» ÁÖÀÇ ±í°Ô ´Ù·ê Çʿ䰡 ÀÖÀ¸¸ç, Áö¼ÓÀûÀÎ Çõ½Å°ú °­·ÂÇÑ µ¥ÀÌÅÍ º¸È£ ÇÁ·¹ÀÓ¿öÅ©ÀÇ Çʿ伺À» °­Á¶ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ[2023] 163¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2024] 177¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ[2030] 295¾ï 3,000¸¸ ´Þ·¯
CAGR(%) 8.77%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀº ¼ö¿ä¿Í °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ÃËÁø¿äÀÎ
    • ¸¸¼ºÁúȯ Áõ°¡
    • ½Ç½Ã°£ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ºñº´¿ø ȯ°æ¿¡¼­ÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
    • ºÒÃæºÐÇÑ »óȯ°ú ³ôÀº ½Ã½ºÅÛ ºñ¿ë
  • ½ÃÀå ±âȸ
    • ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ ±â¼ú ¹ßÀü
    • ÃÖ¼Òħ½À ¹× ºñħ½ÀÀû ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå °úÁ¦
    • ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, ¼÷·ÃµÈ ÀÇ·á Àü¹®°¡ ºÎÁ·

Porter's Five Forces : ¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï »óȲÀ» ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¿ÜºÎÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¸ÖƼ ÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ÀÇ °æÀï »óȲ ÆÄ¾Ç

¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ¸ÖƼ ÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï »óȲÀ» öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµðÀΰ¡?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õÀÇ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¸ÖÆ¼ÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : ±â±â À¯Çüº°

  • °íÁ¤
  • ÈÞ´ë¿ë

Á¦7Àå ¸ÖÆ¼ÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå ½Ã·Â ·¹º§º°

  • ³ôÀ½
  • ³·À½
  • Áß°£

Á¦8Àå ¸ÖÆ¼ÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : ¿¬·ÉÃþº°

  • ¼ºÀÎ
  • ³ëÀÎ
  • ¼Ò¾Æ

Á¦9Àå ¸ÖÆ¼ÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ȨÄÉ¾î ¼³Á¤
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¸ÖƼÆÄ¶ó¹ÌÅÍ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦13Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Abbott Laboratories
  • Baxter International Inc.
  • BioTelemetry, Inc.
  • BIOTRONIK SE & Co KG
  • Boston Scientific Corporation
  • CenTrak, Inc.
  • Compumedics Limited
  • DexCom, Inc.
  • Dragerwerk AG & Co. KGaA
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • Getinge AB
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Omron Corporation
ksm 24.11.28

The Multi-Parameter Patient Monitoring Systems Market was valued at USD 16.39 billion in 2023, expected to reach USD 17.75 billion in 2024, and is projected to grow at a CAGR of 8.77%, to USD 29.53 billion by 2030.

Multi-Parameter Patient Monitoring Systems (MPPM) are integral in healthcare settings, designed to simultaneously track multiple physiological signs such as heart rate, blood pressure, respiratory rate, and temperature. The necessity of these systems is driven by their ability to provide continuous patient monitoring, particularly in critical care units, emergency rooms, and during surgeries, allowing for immediate clinical intervention when necessary. They are used primarily across hospitals, outpatient surgical centers, and homecare settings, underscoring their adaptability and vital role in enhancing patient outcomes. Key growth factors include the rising prevalence of chronic diseases, increasing geriatric population, and advancements in wireless communication technologies that enable seamless connectivity. Moreover, the shift toward personalized healthcare and the integration of MPPMs with telehealth services present significant opportunities for market expansion. Companies can capitalize on these trends by investing in AI-driven analytics and IoT integration to offer predictive insights and improved patient management. However, market growth faces challenges such as high costs associated with advanced systems, regulatory compliance hurdles, and the requirement for skilled personnel to operate these devices. Additionally, issues related to data security and privacy are becoming more prominent, necessitating innovation in cybersecurity. The market is marked by rapid technological advancements with a trend towards miniaturized and portable devices facilitating easier in-home monitoring. To stay competitive, businesses should focus on developing cost-effective, user-friendly, and portable monitoring solutions, along with investing in research around machine learning to enhance predictive capabilities. Overall, fostering partnerships with technology firms and healthcare providers to co-create innovative solutions could offer strategic growth avenues. The MPPM market thus offers ample opportunities but requires careful navigation of obstacles, emphasizing the need for continuous innovation and robust data protection frameworks.

KEY MARKET STATISTICS
Base Year [2023] USD 16.39 billion
Estimated Year [2024] USD 17.75 billion
Forecast Year [2030] USD 29.53 billion
CAGR (%) 8.77%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Multi-Parameter Patient Monitoring Systems Market

The Multi-Parameter Patient Monitoring Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases
    • Rising demand for real-time and remote patients monitoring
    • Growing demand for patient monitoring devices in non-hospital settings
  • Market Restraints
    • Inadequate reimbursement and high cost of system
  • Market Opportunities
    • Technological advancement in patient monitoring systems
    • Rising demand for minimally invasive and non-invasive device
  • Market Challenges
    • Stringent regulatory framework and lack of skilled healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Multi-Parameter Patient Monitoring Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Multi-Parameter Patient Monitoring Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Multi-Parameter Patient Monitoring Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Multi-Parameter Patient Monitoring Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Multi-Parameter Patient Monitoring Systems Market

A detailed market share analysis in the Multi-Parameter Patient Monitoring Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Multi-Parameter Patient Monitoring Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Multi-Parameter Patient Monitoring Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Multi-Parameter Patient Monitoring Systems Market

A strategic analysis of the Multi-Parameter Patient Monitoring Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Multi-Parameter Patient Monitoring Systems Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Baxter International Inc., BioTelemetry, Inc., BIOTRONIK SE & Co KG, Boston Scientific Corporation, CenTrak, Inc., Compumedics Limited, DexCom, Inc., Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, GE Healthcare, Getinge AB, Koninklijke Philips N.V., Medtronic PLC, and Omron Corporation.

Market Segmentation & Coverage

This research report categorizes the Multi-Parameter Patient Monitoring Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across Fixed and Portable.
  • Based on Acuity level, market is studied across High, Low, and Medium.
  • Based on Age Group, market is studied across Adult, Geriatric, and Pediatric.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Homecare Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases
      • 5.1.1.2. Rising demand for real-time and remote patients monitoring
      • 5.1.1.3. Growing demand for patient monitoring devices in non-hospital settings
    • 5.1.2. Restraints
      • 5.1.2.1. Inadequate reimbursement and high cost of system
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in patient monitoring systems
      • 5.1.3.2. Rising demand for minimally invasive and non-invasive device
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory framework and lack of skilled healthcare professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Multi-Parameter Patient Monitoring Systems Market, by Device Type

  • 6.1. Introduction
  • 6.2. Fixed
  • 6.3. Portable

7. Multi-Parameter Patient Monitoring Systems Market, by Acuity level

  • 7.1. Introduction
  • 7.2. High
  • 7.3. Low
  • 7.4. Medium

8. Multi-Parameter Patient Monitoring Systems Market, by Age Group

  • 8.1. Introduction
  • 8.2. Adult
  • 8.3. Geriatric
  • 8.4. Pediatric

9. Multi-Parameter Patient Monitoring Systems Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Homecare Settings
  • 9.4. Hospitals

10. Americas Multi-Parameter Patient Monitoring Systems Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Multi-Parameter Patient Monitoring Systems Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Multi-Parameter Patient Monitoring Systems Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Baxter International Inc.
  • 3. BioTelemetry, Inc.
  • 4. BIOTRONIK SE & Co KG
  • 5. Boston Scientific Corporation
  • 6. CenTrak, Inc.
  • 7. Compumedics Limited
  • 8. DexCom, Inc.
  • 9. Dragerwerk AG & Co. KGaA
  • 10. Edwards Lifesciences Corporation
  • 11. GE Healthcare
  • 12. Getinge AB
  • 13. Koninklijke Philips N.V.
  • 14. Medtronic PLC
  • 15. Omron Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦